Loading…
Based on limited metadata, this FDA Warning Letter issued to Gipsco Investment Corp on July 10, 2018, involves a product category classified as "Other," though the specific product type and regulatory violations are not detailed in the available information. Without access to the full letter text or subject line, the nature and scope of the compliance issues cannot be determined. The issuing office is also not specified in the metadata provided. This summary should be supplemented with the complete warning letter to understand the specific violations and required corrective actions.